Poliovirus antibody levels and lameness among individuals in three regions of Ghana

References

• Roberts L. Infectious disease. Polio outbreak breaks the rules. Science. 2010;330(6012):1730–31. doi:10.1126/science.330.6012.1730.
   PubMed Web of Science ®Google Scholar
• WHO. [accessed 2019 Jan]. http://polioeradication.org/polio-today/polio-now/.
   Google Scholar
• Ghana Health Service (GHS). Disease Surveillance Division. Annual report. 2017.
   Google Scholar
• Reinheimer C, Friedrichs IMK, Rabenau HF, Doerr WH. Deficiency of immunity to poliovirus type 3: a lurking danger. BMC Infect Dis. 2012;12:685–89.
   Web of Science ®Google Scholar
• Philippa MB, White JG. Prevalence of antibody to poliovirus in England and Wales 1984-6. Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1153–55.
   Google Scholar
• Frantzidou F, Diza E, Halkia D, Antoniadis A. A seroprevalence study of poliovirus antibody in the population of northern Greece. Copyright by the European society of clinical microbiology and infectious diseases. CMI. 2004;11:63–82.
   Google Scholar
• Giwa FJ, Olayinka AT, Ogunshola FT. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. Vaccine. 2012 Nov 6;30(48):6759–65. doi:10.1016/j.vaccine.2012.09.023.
   PubMed Web of Science ®Google Scholar
• Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Wannemuehler KA, Pallansch MA, Gajida AU, Pate M, et al. Survey of poliovirus antibodies in Kano, Northern Nigeria. Vaccine. 2014;32:1414–20. doi:10.1016/j.vaccine.2013.08.060.
   PubMed Web of Science ®Google Scholar
• Habib MA, Soofi S, Ali N, Sutter RW, Pallansch MH, Qureshi H, Akhtar T, Molodecky NA, Okayasu H, Zulfiqar A, et al. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine. 2013 Apr 8;31(15):1987–93. doi:10.1016/j.vaccine.2013.02.003.
   PubMed Web of Science ®Google Scholar
• HaiBo W, Hui C, Zheng RD. Seroprevalence of antipolo antibodies among children. J ASM. 2013;Org. (20).
   Google Scholar
• Lapinleimu K. Elimination of poliomyelitis in Finland. Rev Infect Dis. 1984;6:S457–S460.
   PubMedGoogle Scholar
• Alleman MM, Wannemuehler KA, Weldon WC, Kabuayi JP, Ekofo F, Edidi S, Mulumba A, Mbule A, Ntumbannji RN, Coulibaly T, et al. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010–2011, informed by a pre-outbreak poliovirus immunity assessment. J Infect Dis. 2014 Nov 1;210(Suppl 1):S62–S73. doi:10.1093/infdis/jiu282.
   PubMedGoogle Scholar
• de Miranda MP, Gomes MC, de Andrade HR. Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002. Euro Surveill. 2007 Sep;12(9):E070913.4.
   Google Scholar
• Calderon-Margalit R1, Sofer D, Gefen D, Lewis M, Shulman L, Mendelson E, Swartz TA, Shohat T. Immune status to poliovirus among immigrant workers in Israel. Prev Med. 2005 Jun;40(6):685–89. doi:10.1016/j.ypmed.2004.09.008.
   PubMed Web of Science ®Google Scholar
• Nicholas DD, Kratzer JH, Ofosu-Amaah S, Belcher DW. Is poliomyelitis a serious problem in developing countries? The Danfa experience. Br Med J. 1977;1:1009–12. doi:10.1136/bmj.1.6067.1009.
   PubMed Web of Science ®Google Scholar
• Ofosu-Amaah S, Kratzer J, Nicholas DD. Is poliomyelitis a serious problem in developing countries? Lameness in Ghanaian schools. Br Med J. 1977;1:1012–14. doi:10.1136/bmj.1.6067.1012.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Expanded programme on immunization-Burma. WHO Weekly Epidemiol Rec. 1977;52:145–46.
   Google Scholar
• World Health Organization. Survey for residual paralysis-Egypt. WHO Weekly Epidemiol Rec. 1977;52:269–71.
   Google Scholar
• World Health Organization. Expanded programme on immunization- Philippines. WHO Weekly Epidemiol Rec. 1978;53:144–46.
   Google Scholar
• World Health Organization. Expanded programme on immunization, poliomyelitis in Indonesia. WHO Weekly Epidemiol Rec. 1979;54:177–78.
   Google Scholar
• World Health Organization. Expanded programme on immunization, poliomyelitis in Thailand. WHO Weekly Epidemiol Rec. 1979;54:202–03.
   Google Scholar
• Pacho N, Amela C, De Ory F. Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain. Epidemiol Infect. 2002;129:535–41. doi:10.1017/S0950268802007781.
   PubMed Web of Science ®Google Scholar
• Jee YM, Cheon DS, Kim KS, Lee SH, Yoon JD, Lee SW, Go U, Yang BK, Ki MR, Choi BY, et al. A seroprevalence study of poliovirus antibody among primary school children in Korea. Epidemiol Infect. 2004;132:351–55. doi:10.1017/s0950268804002171.
   PubMed Web of Science ®Google Scholar
• Wallace T, Gregory S, Aaron T, William C, Oberste SM. Seroprevalence of poliovirus antibodies in the United States population, 2009–2010. BMC Public Health. 2016;16:72. doi:10.1186/s12889-016-3386-1.
   PubMed Web of Science ®Google Scholar
• Baba MM, Haruna BA, Ogunmola O, Ambe JP, Shidali NN, Oderinde B, Marcello A, Talle M. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria. J Med Virol. 2012 Apr;84(4):691–96. doi:10.1002/jmv.23228.
   PubMed Web of Science ®Google Scholar
• Ghana Health Service (GHS). a polio-free country. Disease Surveillance Division Report. 2015.
   Google Scholar
• Centers for Disease Control and Prevention. Imported wild poliovirus causing poliomyelitis - Bulgaria. MMWR Morb Mortal Wkly Rep. 2001;50(46):1033–35.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Resurgence of wild poliovirus type 1 transmission and consequences of importation - 21 countries, 2002–2005. MMWR Morb Mortal Wkly Rep. 2006;55(6):145–50.
   PubMedGoogle Scholar
• Grassly NC, Fraser C, Wenger J. New strategies for the eradication of polio India. Science. 2006;314:1150–53. doi:10.1126/science.1130388.
   PubMed Web of Science ®Google Scholar
• Grassly NC, Wenger J, Durrani S. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet. 2007;369:1356–62. doi:10.1016/S0140-6736(07)60531-5.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Public health dispatch. An outbreak of poliomyelitis-dominican republic and haiti. MMWR. 2000;49:1049–103.
   Google Scholar
• Anderson RM. The concept of herd immunity and the design of community-based immunization programmes. Vaccine. 1992;10:928–35.
   PubMed Web of Science ®Google Scholar
• Sutter RW, Kew O, Cochi SL. Poliovirus vaccines—live. In: Plotkin SA, Orenstein WA, editors. Vaccines. Vol. ch26. 4th ed. Philadelphia (PA): W.B.Saunders; 2004.
   Google Scholar
• El-Sayed N, Al-Jorf S, Hennessey KA, Salama M, Watkins MA, Abdel Wahab JA, Pallansch MA, Gary H, Wahdan MH, Sutter RW. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt. Vaccine. 2007;25(27):5062–70. doi:10.1016/j.vaccine.2007.04.022.
   Web of Science ®Google Scholar
• HaiBo W, Cui H, Zheng RD. Seroprevalence of antipolo antibodies among children. J ASM. 2013;Org. (20):33.
   Google Scholar
• Frantzidou F, Diza E, Halkia D, Antoniadis A. A seroprevalence study of poliovirus antibody in the population of Northern Greece. Clin Microbiol Infect. 2005;11:68–71. doi:10.1111/j.1469-0691.2004.00998.x.
   PubMed Web of Science ®Google Scholar
• Diedrich S, Hermann C, Eckart S. Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units. BMC Infect Dis. 2002;2:2. doi:10.1186/1471-2334-2-2.
   PubMed Web of Science ®Google Scholar
• Akoua-Koffi G, Thonnon J, Kouassi-Renaud M, Dosso M, Ehouman A. Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan. Bull Soc Pathol Exot. 1995;88:117–20.
   PubMedGoogle Scholar
• Deshpande JM, Kamat JR, Rao VK, Nadkarni SS, Kher AS, Saigaokar SD. Prevalence of antibodies and enteroviruses excreted by healthy children in Bombay. Indian J Med Res. 1995;101:50–54.
   PubMed Web of Science ®Google Scholar
• Bassioni LE, Barakat I, Nasr E, de Gourville EM, Hovi T, Blomqvist S, Burns C, Stenvik M, Gary H, Kew OM, et al. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol. 2003;158(8). doi:10.1093/aje/kwg202.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Progress towards global interruption of wild poliovirus transmission. Wkly Epidemiol Rec. 2012;87:195–200.
   PubMedGoogle Scholar
• Ghana Health Service (GHS). Expanded Programme on Immunization. Half Year Report.2016.
   Google Scholar
• Pírez MC, Olivera I, Diabarboure H, Montano A, Barañano R, Badía F, Bonnet MC. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: implications for future polio vaccination strategies. Vaccine. 2009;27:2689–94. doi:10.1016/j.vaccine.2009.02.042.
   PubMed Web of Science ®Google Scholar
• Schoub BD, Blackburn NK, McAnerney JM. Seroprevalence to polio in personnel at a virology institute. J Infect. 2001;43(2):128–31. doi:10.1053/jinf.2001.0867.
   PubMed Web of Science ®Google Scholar
• Williams JO, David-West TS. Poliovirus antibody in children from a paediatric hospital in Ibadan, Nigeria. Rev Roum Virol. 1990;41:129–32.
   PubMedGoogle Scholar
• Grassly NC. Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. J Infect Dis. 2012;205(10):1554–61. doi:10.1093/infdis/jis213.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Polio. 2013 [accessed 2018 Jul]. http://www.who.int/mediacentre/factsheets/fs114/en/index.html.
   Google Scholar
• Ofosu-Amaah S, Kratzer J, Nicholas DD. Is poliomyelitis a serious problem in developing countries?” Lameness in Ghanaian schools. Br Med J. 1977;1:1012–14. doi:10.1136/bmj.1.6067.1012.
   PubMed Web of Science ®Google Scholar
• Ghana Health Service (GHS). Expanded programme on immunization. Annual Report. 2018.
   Google Scholar
• Opare JKL, Odoom JK, Akweongo P, Afari EA. lameness among individuals in three regions of Ghana. 2017. unpublished.
   Google Scholar
• Boche R. La poliomyelite au Cameroun. Revue d’epidemiologie, medecinesociale et santepublique. 1973;21:79.
   Google Scholar
• Guyer B. The seroepidemiology of poliovirus in Yaounde, Cameroon: a survey following one year of immunization. J Trop Pediatr. 1976;27:140–43. doi:10.1093/tropej/27.3.140.
   Google Scholar
• Heymann L, Virginia DFM, Lichnevski GKM, Flaubert M. Estimation of incidence of poliomyelitis by three survey methods in different regions of the United Republic of Cameroon. Bull World Health Organ. 1983;61(3):501–07. World Health Organization.
   PubMed Web of Science ®Google Scholar
• Collingham KE, Pollock TM, Roebuck MO. Paralytic poliomyelitis in England and Wales 1976-7. Lancet. 1978 May 6;1(8071):976–77. doi:10.1016/s0140-6736(78)90360-4.
   PubMed Web of Science ®Google Scholar
• Rotti SB, Satpathy SK, Mehta SP. Prevalence of paralytic poliomyelitis in Pondicherry, South India. Epidemioll Commun Health. 1982;36:279–81. doi:10.1136/jech.36.4.279.
   PubMed Web of Science ®Google Scholar
• Horstmann D. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc. 1950;142(4):236–41. doi:10.1001/jama.1950.02910220016004.
   PubMed Web of Science ®Google Scholar
• Cochran WG. Sampling techniques. 3rd ed. New York (NY): John Wiley and Sons; 1977.
   Google Scholar
• Ghana Education Service (GES). Enrolment in Schools. Education Management Information System (EMIS) Ghana. 2016. http://www.ghanaeducationdata.com.
   Google Scholar
• WHO. Manual the virological investigation of polio. Global programme for vaccines and immunization. Expanded programme on immunization. Geneva: WHO; 1997.
   Google Scholar
• Laforce FM, Lichnevski MS, Keja J, Henderson RH. Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries. Bull World Health Organ. 1980;58:609–20.
   PubMed Web of Science ®Google Scholar